Boehringer Ingelheim 2014 empagliflozin EMPA-REG; modern modern foundational text + cardio-renal-protection + 2024 broader heart-failure indication.
Boehringer Ingelheim 2014 empagliflozin EMPA-REG; modern modern foundational text + cardio-renal-protection + 2024 broader heart-failure indication.